Literature DB >> 7082992

A post-mortem study of the cholinergic and GABA systems in senile dementia.

M N Rossor, N J Garrett, A L Johnson, C Q Mountjoy, M Roth, L L Iversen.   

Abstract

Choline acetyltransferase (ChAT) activity and gamma-aminobutyric acid (GABA) concentration were measured in 19 cerebral cortical areas and 22 subcortical areas of brains from 26 control and 25 histologically proven cases of Alzheimer's disease. Reduced ChAt activity was observed in all the cortical areas examined in the Alzheimer cases dying before the median age of 79 years. In the Alzheimer cases aged greater than 79 years at death, 7 out of the 9 frontal cortical areas had a normal ChAT activity when compared with controls. Significant reductions in GABA concentrations in the Alzheimer cases were confined to the temporal cortex. Significant reductions in ChAT activity in subcortical areas were confined to 8 of the 22 regions examined. Notably these included the septal nuclei and substantia innominata, the proposed origins of the cholinergic projections to the hippocampus and neocortex, respectively. There were no reductions in GABA concentrations outside the cerebral cortex. Four multi-infarct cases and 6 cases with normal histology were found to have a small reduction in ChAT activity confined to only a few areas. The data are consistent with a predominant loss in Alzheimer's disease of the diffuse cholinergic projection from the brainstem and basal forebrain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082992     DOI: 10.1093/brain/105.2.313

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  56 in total

Review 1.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

2.  Relations between on-off phenomena and cognitive functions in Parkinson disease.

Authors:  G Meco; V Bonifati; L Bedini; A Bellatreccia; N Vanacore; A Franzese
Journal:  Ital J Neurol Sci       Date:  1991-02

3.  Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease.

Authors:  K W Lange; F R Wells; M N Rossor; P Jenner; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

4.  Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials.

Authors:  A T Smith; F Early; G H Jones
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task.

Authors:  J L Muir; S B Dunnett; T W Robbins; B J Everitt
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

6.  Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

Authors:  H Tohgi; T Abe; M Kimura; M Saheki; S Takahashi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.

Authors:  A Little; R Levy; P Chuaqui-Kidd; D Hand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

8.  MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.

Authors:  S George; E J Mufson; S Leurgans; R C Shah; C Ferrari; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2009-12-14       Impact factor: 4.673

Review 9.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

10.  Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type.

Authors:  A Najlerahim; D M Bowen
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.